Delaware's biotechnology industry includes leaders such as AgilentTechnologies, Adesis, DuPont, Intervet, MIDI, Syngenta, and the U.S. headquarters of AstraZeneca, one of the largest pharmaceutical companies in the world. Examples of other companies include ANP Technologies, ParagonRx, Quest Pharmaceutical Services, MIDI, and Scientific Products & Systems.
Delaware Technology Park, a 40-acre research center, supports Delaware's science-based growth. A partnership among the state of Delaware, the University of Delaware, and the private sector, Delaware Technology Park is home to some of the most innovative start-up companies and research centers in the region, including theDelaware Biotechnology Institute and the Fraunhofer Center for Molecular Biotechnology.
Delaware's basic building blocks such as leading academic institutions, targeted state and local economic development programs, and venture capital funding have proven to be attractive to biotechnology and life sciences companies.